Constella
Constella is a medicine authorised by Swissmedic under authorisation number 62684. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 June 2013 and the authorisation is valid without a time limit. ATC code A06AX04 places the medicine in the group Drugs for constipation.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Constella, Kapseln | B | 20 June 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 28 | Kapsel(n) | A06AX04 | 04.08.11 | B |
| 4 | 90 | Kapsel(n) | A06AX04 | 04.08.11 | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Constella authorised in Switzerland?
Yes. Constella is authorised by Swissmedic under authorisation number 62684, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Constella have?
Constella is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Constella?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.